With the second quarter of 2025 now over a month old, many investment funds will soon begin disclosing what stocks…
There is plenty of movement in equity markets during earnings season, but from a fundamental standpoint, investment theses seldom change.…
…
U.S. judge supports FDA decision on Eli Lilly’s weight loss drugs…
Good news for Hims & Hers stock spooks Lilly and Novo investors.…
Good news for Hims & Hers stock spooks Lilly and Novo investors.…
Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to…
Investors are buying Hims & Hers Health (NYSE: HIMS) stock hand over fist after the mail-order drugs company reported an…
Any time is a great time to buy stocks -- if you pick the right stocks. Thats true even in…
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns…
…
…
GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…
For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…
The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli…
We suspect the CVS Health change, which goes into effect on July 1, could put a temporary overhang on Eli…
…
These are the stocks posting the largest moves in midday trading.…
Shares of Eli Lilly (NYSE: LLY) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The…
Apple (AAPL), Airbnb (ABNB), Mastercard (MA), Eli Lilly (LLY), and McDonalds (MCD) are the stocks to watch on Thursday. Read…
Ricks said reshoring manufacturing capacity for older essential medicines is "a valid thing," adding that Eli Lilly is "happy to…
INDIANAPOLIS (dpa-AFX) - Der US-Pharmahersteller Eli Lilly hat wegen Abschreibungen auf einen Zukauf seine Gewinnerwartung…
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.…
Eli Lilly on Thursday posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss drug, Zepbound, came…
Eli Lilly and Co (NYSE:LLY) shares fell as much as 7.7% at the open on Thursday after the drugmaker cut…
Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…
Equity markets have been volatile this year due to macroeconomic and geopolitical factors. Many of the worlds largest corporations havent…
Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies…
Trumps tariffs threats have left the countrys status as the top global investment magnet in doubt.…
CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are…
By David Shepardson WASHINGTON (Reuters) -CEOs and other executives from Nvidia, Johnson & Johnson, Toyota Motor, Eli Lilly and SoftBank…
Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.…
…
Shares have advanced about 15% in 2025.…
These are the stocks posting the largest moves in premarket trading.…
Investor focus is likely to be on the sales numbers of LLYs tirzepatide medicines Mounjaro and Zepbound.…
Investor focus is likely to be on the sales numbers of LLYs tirzepatide medicines Mounjaro and Zepbound.…
Plenty of stocks with attractive businesses trade on the market for hundreds of dollars per share -- or more. However,…
Lilly (LLY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and…
Eli Lilly (NYSE: LLY) has been growing its sales at a good clip over the past year. This is partly…
These are the stocks posting the largest moves in premarket trading.…
Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) stock cut his…
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lillys weight-loss drug Zepbound and its diabetes…
Eli Lilly (LLY) closed at $827.54 in the latest trading session, marking a +1.16% move from the prior day.…
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However,…
Numerous companies have unveiled investments in U.S. manufacturing in recent weeks, including TSMC, Eli Lilly, Hyundai Motor Group and others.…
Eli Lilly ist der Top-Profiteur nadelfreier Alternativen auf dem boomenden Markt für Gewichtsverlust und Diabetes. Veröffentlichung der Studiendaten zu…
Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since…
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around…